Transdermal Pain Relief and Skin Treatment Compositions
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of oral pain relief compositions to develop novel transdermal compositions for treating skin irritations, nail fungus, and preventing skin infections, offering a new paradigm for topical pain relief and skin care.
Background and Problem Solved
The original patent disclosed compositions for oral pain relief, addressing the need for effective pain management in dental care. However, skin irritations, nail fungus, and skin infections are prevalent issues that require innovative solutions. The new inventive concept adapts the core technology to tackle these unmet needs, providing a transdermal approach that bypasses oral administration and targets specific skin conditions.
Detailed Description of the Inventive Concept
The inventive concept comprises dissolvable carriers containing a combination of active ingredients, including guaiacol, eugenol, glycerin, menthol oil, peppermint oil, oregano oil, and cardamom oil. These carriers are designed to adhere to surfaces exhibiting skin irritations, nail fungus, or skin conditions, and dissolve over time to release the active ingredients. The compositions can be formulated as systems, methods, or topical applications, offering versatility in treating various skin-related issues.
Novelty and Inventive Step
The new claims introduce the concept of transdermal delivery of the active ingredients, which is a significant departure from the original oral pain relief compositions. The inventive step lies in the adaptation of the core technology to address unmet needs in skin care, leveraging the unique properties of the active ingredients to provide effective pain relief and treatment of skin conditions.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include varying the ratio of active ingredients, incorporating additional ingredients for enhanced efficacy, or developing customized carriers for specific skin conditions. Variations could also involve using different types of carriers, such as patches, gels, or creams, to expand the range of applications.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the skin care and dermatology markets, addressing a wide range of skin-related issues. Target industries include pharmaceuticals, cosmetics, and personal care, with potential applications in wound care, dermatological treatments, and over-the-counter pain relief products.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/006 |
| A | A61 | A61K31/045 |
| A | A61 | A61K31/047 |
| A | A61 | A61K31/085 |
| A | A61 | A61K36/53 |
| A | A61 | A61K36/534 |
| A | A61 | A61K36/9064 |
| A | A61 | A61K47/10 |
| A | A61 | A61K47/26 |
| A | A61 | A61P23/02 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical compositions and topical drug delivery systems, specifically focusing on pain relief and skin treatment formulations involving essential oils and natural compounds
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced training in pharmaceutical sciences, organic chemistry, and drug delivery technologies, possessing expertise in formulating therapeutic compositions with natural ingredients and understanding transdermal/topical delivery mechanisms
Obviousness Rationale
A PHOSITA would recognize that the transdermal application of the source patent's oral pain relief composition represents a predictable extension of the original technology, leveraging the known therapeutic properties of the active ingredients in a different delivery format. The core chemical composition remains substantially unchanged, with only the carrier and application method being modified. The essential oils and compounds demonstrate well-understood antiseptic, analgesic, and anti-inflammatory properties that would naturally suggest broader application beyond oral contexts.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,676 |
|---|---|
| Title | Compositions for oral pain relief |
| Assignee(s) | ORCA PRODUCTS, LLC |